Page last updated: 2024-08-23

norgestimate and dehydroepiandrosterone

norgestimate has been researched along with dehydroepiandrosterone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jung-Hoffmann, C; Kuhl, H; Wiegratz, I	1
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM	1
Cibula, D; Fanta, M; Hill, M; Sindelka, G; Skrha, J; Zivny, J	1

Trials

2 trial(s) available for norgestimate and dehydroepiandrosterone

Article	Year
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception, 1995, Volume: 51, Issue:6 Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone	1995
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives. International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2 Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone	1995

Article

Year

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.

Contraception, 1995, Volume: 51, Issue:6

Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone

1995

Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.

International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

1995

Other Studies

1 other study(ies) available for norgestimate and dehydroepiandrosterone

Article	Year
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:1 Topics: Adult; Androstenedione; Blood Glucose; Body Constitution; Body Mass Index; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucose Clamp Technique; Humans; Insulin; Luteinizing Hormone; Metabolic Clearance Rate; Norgestrel; Polycystic Ovary Syndrome; Testosterone	2002

Article

Year

Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.

Human reproduction (Oxford, England), 2002, Volume: 17, Issue:1

Topics: Adult; Androstenedione; Blood Glucose; Body Constitution; Body Mass Index; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucose Clamp Technique; Humans; Insulin; Luteinizing Hormone; Metabolic Clearance Rate; Norgestrel; Polycystic Ovary Syndrome; Testosterone

2002